Sulfalene
Systematic (IUPAC) name | |
---|---|
4-Amino-N-(3-methoxypyrazinyl)benzenesulfonamide | |
Clinical data | |
Trade names | Eadazine, Kelfizina, Kelfizine W, Longum |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral[1] |
Pharmacokinetic data | |
Protein binding | 60 to 80%[1] |
Biological half-life | 60 to 65 hours[1] |
Excretion | Urinary[1] |
Identifiers | |
CAS Number | 152-47-6 |
ATC code | J01ED02 QJ01EQ19 |
PubChem | CID 9047 |
DrugBank | DB00664 |
ChemSpider | 8695 |
UNII | T6BL4ZC15G |
KEGG | D01216 |
Synonyms | Sulfametopyrazine |
Chemical data | |
Formula | C11H12N4O3S |
Molar mass | 280.304 g/mol |
| |
| |
(verify) |
Sulfalene (INN, USAN) or sulfametopyrazine (BAN) is a long-acting sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria.[2][3] There are only two countries in which it is currently still marketed: Thailand and Ireland.[3]
Synthesis
See also
References
- 1 2 3 4 "Sulfalene". MIMS Drug Information System. Retrieved 26 August 2011.
- ↑ DrugBank DB00664
- 1 2 Brayfield, A, ed. (9 May 2013). "Sulfametopyrazine". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 28 March 2014.
- ↑ Camerino, B.; Palamidessi, G., Gazz. Chim. Ital., (1960) 90, 1815.
|
This article is issued from Wikipedia - version of the Saturday, January 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.